SearchNewsletter

Past briefings

Wednesday, September 30, 2026

The top medical stories of the day, as they ran.

Morning edition

15 stories

  1. 1Kennedy calls for broader access to health data for researchResearch · 5 outlets
  2. 2Lilly reports retatrutide weight loss in phase 3 trial for diabetes and obesityDrugs and FDA · 4 outlets
  3. 3UniQure gene therapy misses significance on four-year Huntington’s disease measureDrugs and FDA · 4 outlets
  4. 4CDC updates measles tally to include a second deathOutbreaks · 2 outlets
  5. 5Burnham proposes pension reform to fund national care serviceHealth policy · 3 outlets
  6. 6AstraZeneca invests $2 billion in Summit to test cancer drug combinationsIndustry · 4 outlets
  7. 7FDA approves tiratricol as first treatment for MCT8 deficiencyDrugs and FDA · 2 outlets
  8. 8Vitruvias recalls 30-mg thyroid tablets over excessive potencyDrug safety · 2 outlets
  9. 9Montana’s early Medicaid work rules confuse enrolleesMedicare and Medicaid · 2 outlets
  10. 10Roche and Zealand report 9.8% weight loss with middle dose of petrelintideDrugs and FDA · 2 outlets
  11. 11Novo licenses Hengrui’s preclinical obesity drug candidate for up to $2.6 billionIndustry · 3 outlets
  12. 12CooperSurgical recalls INCA infant CPAP sets over loose connectionsMedical devices · 1 outlet
  13. 13Poll finds rural voters see little impact from Trump health policiesHealth policy · 2 outlets
  14. 14Leading FDA Is an Impossible Job Right Now. Heidi Overton Could Still Do It WellHealth policy · 2 outlets
  15. 15Lindsay Clancy’s lawyer challenges evidence that she killed her childrenMental health · 2 outlets

Evening edition

19 stories

  1. 1Pennsylvania reports fifth measles-related death as outbreak reaches 39 countiesOutbreaks · 3 outlets
  2. 2Lilly reports phase 3 retatrutide weight-loss results in adults with diabetesDrugs and FDA · 5 outlets
  3. 3Kennedy calls for broader access to health data for researchResearch · 6 outlets
  4. 4Lilly’s amylin-Zepbound combination led to 23.3% weight loss in trialResearch · 3 outlets
  5. 5Roche and Zealand report phase 2 petrelintide weight-loss resultsDrugs and FDA · 3 outlets
  6. 6Three Florida counties declare emergencies amid locally acquired dengue outbreakOutbreaks · 2 outlets
  7. 7Rural MAHA supporters see little health benefit from Trump policiesHealth policy · 4 outlets
  8. 8Medicaid changes put hundreds of thousands of legal immigrants at risk of losing coverageMedicare and Medicaid · 2 outlets
  9. 9Insurers cut Medicare Advantage plans for 2027Medicare and Medicaid · 2 outlets
  10. 10VA requires consent before prescribing antidepressants to veterans under 30Health policy · 2 outlets
  11. 11AstraZeneca invests $2 billion in Summit to test cancer drug combinationsIndustry · 3 outlets
  12. 12Bristol Myers reports liver safety events, including a patient death, in trialDrug safety · 2 outlets
  13. 13Merck reports phase 2b success for tulisokibart in hidradenitis suppurativaResearch · 2 outlets
  14. 14Essentia Health and HealthPartners announce merger plansIndustry · 2 outlets
  15. 15ACC statement urges overall diet quality for cardiovascular healthHeart health · 2 outlets
  16. 16Two people charged in alleged counterfeit Ozempic distribution schemeDrug safety · 2 outlets
  17. 17UniQure gene therapy misses significance on four-year Huntington’s disease measureDrugs and FDA · 2 outlets
  18. 18England to expand Healthy Babies programme to all local authoritiesPublic health · 2 outlets
  19. 19Lindsay Clancy’s lawyer challenges evidence that she killed her childrenMental health · 2 outlets